128 related articles for article (PubMed ID: 1730176)
1. Transdermally administered fentanyl for pain management.
Calis KA; Kohler DR; Corso DM
Clin Pharm; 1992 Jan; 11(1):22-36. PubMed ID: 1730176
[TBL] [Abstract][Full Text] [Related]
2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing quality of life in cancer patients: the role of transdermal fentanyl in the management of pain.
Payne R
Semin Oncol; 1998 Jun; 25(3 Suppl 7):47-53. PubMed ID: 9671331
[TBL] [Abstract][Full Text] [Related]
4. [Fentanyl-TTS for postoperative pain therapy. A new alternative?].
Donner B; Zenz M; Tryba M; Kurz-Müller K
Anaesthesist; 1993 May; 42(5):309-15. PubMed ID: 8317689
[TBL] [Abstract][Full Text] [Related]
5. Disposition of transdermally administered fentanyl in dogs.
Kyles AE; Papich M; Hardie EM
Am J Vet Res; 1996 May; 57(5):715-9. PubMed ID: 8723888
[TBL] [Abstract][Full Text] [Related]
6. Fentanyl HCl patient-controlled iontophoretic transdermal system for the management of acute postoperative pain.
Mayes S; Ferrone M
Ann Pharmacother; 2006 Dec; 40(12):2178-86. PubMed ID: 17164395
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the analgesic properties of transdermally administered fentanyl and intramuscularly administered buprenorphine during and following experimental orthopedic surgery in sheep.
Ahern BJ; Soma LR; Boston RC; Schaer TP
Am J Vet Res; 2009 Mar; 70(3):418-22. PubMed ID: 19254157
[TBL] [Abstract][Full Text] [Related]
8. Transdermal fentanyl in cancer pain.
Mosser KH
Am Fam Physician; 1992 May; 45(5):2289-94. PubMed ID: 1575123
[TBL] [Abstract][Full Text] [Related]
9. A safe and effective method for converting patients from transdermal to intravenous fentanyl for the treatment of acute cancer-related pain.
Kornick CA; Santiago-Palma J; Schulman G; O'Brien PC; Weigand S; Payne R; Manfredi PL
Cancer; 2003 Jun; 97(12):3121-4. PubMed ID: 12784350
[TBL] [Abstract][Full Text] [Related]
10. Iontophoretic drug delivery system: focus on fentanyl.
Herndon CM
Pharmacotherapy; 2007 May; 27(5):745-54. PubMed ID: 17461710
[TBL] [Abstract][Full Text] [Related]
11. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.
Tawfik MO; Bryuzgin V; Kourteva G;
Curr Med Res Opin; 2004 Mar; 20(3):259-67. PubMed ID: 15025835
[TBL] [Abstract][Full Text] [Related]
12. Current practices for postoperative pain management in Europe and the potential role of the fentanyl HCl iontophoretic transdermal system.
Rawal N; Langford RM
Eur J Anaesthesiol; 2007 Apr; 24(4):299-308. PubMed ID: 17156510
[TBL] [Abstract][Full Text] [Related]
13. [Transcutaneous fentanyl].
Estève M
Cah Anesthesiol; 1994; 42(2):195-217. PubMed ID: 8087637
[TBL] [Abstract][Full Text] [Related]
14. [Home palliative care--2 case reports: a long-term cancer pain management with transdermal fentanyl].
Fujimoto M; Sakuyama T; Mizutani Y; Kuroda T; Yanaga K
Gan To Kagaku Ryoho; 2004 Dec; 31 Suppl 2():190-3. PubMed ID: 15645768
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
[TBL] [Abstract][Full Text] [Related]
16. Transdermal fentanyl in cachectic cancer patients.
Heiskanen T; Mätzke S; Haakana S; Gergov M; Vuori E; Kalso E
Pain; 2009 Jul; 144(1-2):218-22. PubMed ID: 19442446
[TBL] [Abstract][Full Text] [Related]
17. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
Sittl R; Likar R; Nautrup BP
Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of safety and efficacy of transdermal therapeutic system-fentanyl in adult patients with gynecological cancer-related pain.
Lorvidhaya V; Katanyoo K; Srisomboon J; Suprapaphorn P; Cheewakriangkrai C
J Med Assoc Thai; 2004 Mar; 87(3):319-25. PubMed ID: 15117050
[TBL] [Abstract][Full Text] [Related]
19. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.
Likar R; Kayser H; Sittl R
Clin Ther; 2006 Jun; 28(6):943-52. PubMed ID: 16860176
[TBL] [Abstract][Full Text] [Related]
20. Transdermal therapeutic fentanyl-system (TTS-F).
Mystakidou K; Katsouda E; Tsilika E; Parpa E; Vlahos L
In Vivo; 2004; 18(5):633-42. PubMed ID: 15523905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
